Financial Counselors Inc Jazz Pharmaceuticals PLC Transaction History

Financial Counselors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$115.19 - $132.77 $60,129 - $69,305	522 Added 28.16%	2,376 $286,000
Q4 2023 Jan 26, 2024	BUY	$114.26 - $136.0 $5,141 - $6,120	45 Added 2.49%	1,854 $228,000
Q3 2023 Nov 07, 2023	BUY	$122.0 - $145.31 $4,026 - $4,795	33 Added 1.86%	1,809 $234,000
Q2 2023 Jul 27, 2023	SELL	$122.5 - $147.16 $7,105 - $8,535	-58 Reduced 3.16%	1,776 $220,000
Q1 2023 May 02, 2023	BUY	$133.98 - $160.47 $2,143 - $2,567	16 Added 0.88%	1,834 $268,000
Q3 2022 Nov 01, 2022	BUY	$126.59 - $161.18 $230,140 - $293,025	1,818 New	1,818 $242,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Counselors Inc with notifications on news.